Tag: Prescription Drugs
Little Benefit for Etanercept-MTX Before Triple Therapy in RA
First-line etanercept-methotrexate would result in 0.15 additional lifetime QALY, at cost of $77,290
Targeting ANGPTL3 Can Significantly Lower Cholesterol
Two trials show promise for non-statin approach to cardiovascular disease prevention
ATS: Benralizumab Reduces Glucocorticoid Doses in Asthma
Significant 75 percent reduction in median final oral glucocorticoid doses from baseline
ATS: Angiotensin II Improves BP in Vasodilatory Shock
Angiotensin II effective for vasodilatory shock in patients not responding to conventional vasopressors
Patients Often Prescribed Futile Drugs in Last Months of Life
Researchers find many still prescribed long-term disease-preventing medications
KIT Inhibition by Imatinib Helps Severe Refractory Asthma
Improvement in airway hyperresponsiveness seen with imatinib versus placebo
Lower-, Higher-Dose Elagolix Beneficial for Endometriosis
Higher percentage of women have clinical response for dysmenorrhea, non-menstrual pelvic pain
ASCO: Capecitabine May Extend Survival in Biliary Tract Cancer
Survival benefit seen in those given capecitabine versus surgery alone
Researchers Say PDE5 Inhibitors Don’t Cause Melanoma
Any connection appears to be due to detection bias, investigators conclude
Findings Support Lower Doses of Atropine in Pediatric Myopia Rx
Efficacy of atropine is independent of dose, while adverse effects are dose dependent
